Insights from our specialists, treatment updates, clinic news and patient recommendations.
Rheumatology
Pfizer announced that the U.S. Food and Drug Administration (FDA) has approved Ixifi (infliximab qbtx) as a biosimilar medication
Allergology
Allergology at Horev Medical: American Academy of Allergy guidelines recommend intranasal corticosteroids as first-line treatment for seasonal rhinitis in patients aged 12 and older.
Ophthalmology
Gene therapy for hereditary retinal dystrophy has received drug-agency approval
Liver tumor
A new study has been conducted on using this drug to treat liver carcinoma via intrahepatic injection
Neurology
New studies offer hope for boosting brain function as we age. A randomized clinical trial in adults aged 56–71 explored the effects of cognitive training.
Neurosurgery
New research shows that transferring the cervical C7 nerve from the non-paralysed side to the paralysed side in patients after stroke or other brain injuries improves arm function.
Surgery
A new robotic-assisted surgical system (Senhance System) has been approved for use in laparoscopic colorectal and gynecological operations
Oncogynecology
Breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers: expert assessment and evaluation.
OTOLARYNGOLOGY
The U.S. Food and Drug Administration (FDA) approved Sinuva (mometasone furoate — a corticosteroid with strong anti-inflammatory action).
Esophageal diseases — Barrett's esophagus
Efficacy of liquid nitrogen cryotherapy for Barrett's esophagus after endoscopic resection of intramucosal cancer.
Orthopaedics
Minimally invasive treatment of back pain and the search for non-addictive painkillers: recent advances in orthopaedics.
Dermatology
A drug has been approved for treating cases of teenage psoriasis that are resistant to standard therapy